Espinosa-DiezCMiguelVMennerichDKietzmannTSnchez-PrezPCadenasSet al
Mechanism of action: Both drugs fall into the class of medications known as GLP-1 receptor agonists that enhance insulin secretion, suppress glucagon release, and slow gastric emptying to help control blood sugar levels
Being overweight or obese increases the risk of several severe health conditions, including heart disease, stroke, diabetes, and certain types of cancer
Da Silva Cunha IB, Salomo K, Shimizu M, Bankova VS, Custdio AR, de Castro SL, Marcucci MC
According to Wheeler, while patients who start GLP 1's must take them for life, maintaining supply of the drug can be difficult and expensive